MILAN, Aug. 9 (Class Editori) — Labomar will include Berenberg in its shareholders. Through LBM Holding, the full-service company specialized in the production of medical devices, food supplements and cosmetics will give the German investor 700,000 shares, namely 3.79% of the overall outstanding ones, for 12.70 euros each, which means with an around 5% discount on the 13.35-euro closing price recorded on July 30. The transaction's value amounts to 8.89 million eurosand therefore the stake of Walter Bertin, CEO and Founder of Labomar, through LBM Holding decreased from 71.1% to 67.3%.
"We have been long discussing Berenberg's entry into the capital of Labomar. The presence among our shareholders of such a relevant investor that is globally recognized and renowned represents a very important step forward for our company," Mr. Bertin explained. According to him, this operation crowns a path characterized by a growing interest in Labomar in the last quarter also from investors usually less focused on Italian Small Caps.
"This interest gratifies us and rewards the strategic choices made by our company, but also confirms Italian excellence in research and production of food supplements and medical devices. I am also confident that the increase in free float will be appreciated by all our investors," Mr. Bertin added.
Banca Mediolanum (as NOMAD) and Intesa Sanpaolo, IMI Corporate & Investment Banking division (as global coordinator), granted a waiver to the lock-up agreements signed with LBM Holding prior to the listing. The transaction was coordinated by Bmodel as corporate financial advisor, with the Founder Claudio De Nadai and the Senior Partner Martina Torresan, while CFO SIM acted as corporate broker. Labomar's stock, listed on the AIM segment of Borsa Italiana, rose 0.36% to 13.85 euros. (All rights reserved)
Notice: No person, organization and/or company shall disseminate or broadcast the above article on Xinhua Silk Road website without prior permission by Xinhua Silk Road.